» Articles » PMID: 36986884

The Potential Use of Exosomes in Anti-Cancer Effect Induced by Polarized Macrophages

Overview
Journal Pharmaceutics
Publisher MDPI
Date 2023 Mar 29
PMID 36986884
Authors
Affiliations
Soon will be listed here.
Abstract

The rapid development of aberrant cells outgrowing their normal bounds, which can subsequently infect other body parts and spread to other organs-a process known as metastasis-is one of the significant characteristics of cancer. The main reason why cancer patients die is because of widespread metastases. This abnormal cell proliferation varies in cancers of over a hundred types, and their response to treatment can vary substantially. Several anti-cancer drugs have been discovered to treat various tumors, yet they still have harmful side-effects. Finding novel, highly efficient targeted therapies based on modifications in the molecular biology of tumor cells is essential to reduce the indiscriminate destruction of healthy cells. Exosomes, an extracellular vesicle, are promising as a drug carrier for cancer therapy due to their good tolerance in the body. In addition, the tumor microenvironment is a potential target to regulate in cancer treatment. Therefore, macrophages are polarized toward M1 and M2 phenotypes, which are involved in cancer proliferation and are malignant. It is evident from recent studies that controlled macrophage polarization might contribute to cancer treatment, by the direct way of using miRNA. This review provides an insight into the potential use of exosomes to develop an 'indirect', more natural, and harmless cancer treatment through regulating macrophage polarization.

Citing Articles

Vitamin D and allergic diseases.

Zhang P, Xu Q, Zhu R Front Immunol. 2024; 15:1420883.

PMID: 39026686 PMC: 11254667. DOI: 10.3389/fimmu.2024.1420883.


Macrophage polarization: an important role in inflammatory diseases.

Luo M, Zhao F, Cheng H, Su M, Wang Y Front Immunol. 2024; 15:1352946.

PMID: 38660308 PMC: 11039887. DOI: 10.3389/fimmu.2024.1352946.


Marine Plasmalogens: A Gift from the Sea with Benefits for Age-Associated Diseases.

Yamashita S, Miyazawa T, Higuchi O, Kinoshita M, Miyazawa T Molecules. 2023; 28(17).

PMID: 37687157 PMC: 10488995. DOI: 10.3390/molecules28176328.

References
1.
Behmoaras J . The versatile biochemistry of iron in macrophage effector functions. FEBS J. 2020; 288(24):6972-6989. DOI: 10.1111/febs.15682. View

2.
Tan A, Rajadas J, Seifalian A . Exosomes as nano-theranostic delivery platforms for gene therapy. Adv Drug Deliv Rev. 2012; 65(3):357-67. DOI: 10.1016/j.addr.2012.06.014. View

3.
Chen Y, Ma X, Lou C, Zhou C, Zhao X, Li N . PLA2G10 incorporated in exosomes could be diagnostic and prognostic biomarker for non-small cell lung cancer. Clin Chim Acta. 2022; 530:55-65. DOI: 10.1016/j.cca.2022.02.016. View

4.
Zhang B, Yang Y, Yi J, Zhao Z, Ye R . Hyperglycemia modulates M1/M2 macrophage polarization via reactive oxygen species overproduction in ligature-induced periodontitis. J Periodontal Res. 2021; 56(5):991-1005. DOI: 10.1111/jre.12912. View

5.
Li Z, Suo B, Long G, Gao Y, Song J, Zhang M . Exosomal miRNA-16-5p Derived From M1 Macrophages Enhances T Cell-Dependent Immune Response by Regulating PD-L1 in Gastric Cancer. Front Cell Dev Biol. 2020; 8:572689. PMC: 7734296. DOI: 10.3389/fcell.2020.572689. View